Scherer S J, Avdievich E, Edelmann W
Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Biochem Soc Trans. 2005 Aug;33(Pt 4):689-93. doi: 10.1042/BST0330689.
Mutations in MMR (DNA mismatch repair) genes underlie HNPCC (hereditary non-polyposis colon cancer) and also a significant proportion of sporadic colorectal cancers. MMR maintains genome stability and suppresses tumour formation by correcting DNA replication errors and by mediating an apoptotic response to DNA damage. Analysis of mouse lines with MMR missense mutations demonstrates that these MMR functions can be separated and allows the assessment of their individual roles in tumour suppression. These studies in mice indicate that, although the increased mutation rates caused by MMR defects are sufficient to drive tumorigenesis, both functions co-operate in tumour suppression.
错配修复(MMR,DNA mismatch repair)基因的突变是遗传性非息肉病性结直肠癌(HNPCC,hereditary non-polyposis colon cancer)的基础,也是相当一部分散发性结直肠癌的病因。错配修复通过纠正DNA复制错误以及介导对DNA损伤的凋亡反应来维持基因组稳定性并抑制肿瘤形成。对具有错配修复错义突变的小鼠品系的分析表明,这些错配修复功能可以分开,并且能够评估它们在肿瘤抑制中的各自作用。小鼠中的这些研究表明,虽然错配修复缺陷导致的突变率增加足以驱动肿瘤发生,但这两种功能在肿瘤抑制中相互协作。